ChiCTR1900020756
Untitled Trial
Study of the Relationship among rectus femoris cross sectional area and handgrip strength and Medical Research Council Sum‐Score in patients with Intensive Care Unit Acquired Weakness: a prospective cohort study
Department of Intensive Care Unit，the First Affiliated Hospital of Guangzhou University of Chinese Medicine·Chinese Clinical Trial RegistryNot yet recruiting
View on Chinese Clinical Trial Registry →Study focus
- Disease/Condition
- Intensive Care Unit Acquired Weakness
- Drug/Device/Intervention
- (1) After the subject enters the ICU, the subject is measured by a professionally trained ICU physician on the 1st, 3rd, 5th, 7th, 10th, and 14th day of the ICU, or the time of discharge from ICU). The cross sectional area of the rectus femoris muscle in the lower third of the connection between the anterior superior iliac spine and upper of the patella. Subjects' CSA measurements were performed by the same ICU physician, while another ICU physician performed a spot check on patients who required CSA measurements at a fixed time point. (2)The MRC SS score and grip strength of the subject were evaluated by the professional when the subject was awake. If MRC SS
Sponsor & location
- Primary sponsor
- Department of Intensive Care Unit，the First Affiliated Hospital of Guangzhou University of Chinese Medicine
- Funder
- self financing
- Location
- China
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- Jan 31, 2021
ICD-10 classifications
Acute respiratory failureAcute renal failure with medullary necrosisAcute renal failureAcute renal failure, unspecifiedOther acute renal failure
Data source
- Registry
- Chinese Clinical Trial Registry
- Trial ID
- ChiCTR1900020756
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for ChiCTR1900020756 through Pure Global AI's free database. This phase not specified trial is sponsored by Department of Intensive Care Unit，the First Affiliated Hospital of Guangzhou University of Chinese Medicine and is currently Not yet recruiting. The study focuses on Intensive Care Unit Acquired Weakness.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.